Is cognitive–behavioral therapy more effective than other therapies?A meta-analytic review

Tolin, David F.

doi:10.1016/j.cpr.2010.05.003

Cited by 541 publications

(353 citation statements)

References 71 publications

Supporting

Mentioning

312

Contrasting

Unclassified

Order By: Relevance

“…Our findings are in line with Manicavasgar et al (25), demonstrating effectiveness of group MBCT and CBT in reducing depression. These and our findings show that CBT is effective but not superior to some other active treatments (38). Our results are innovative, as this is the first RCT study on the effectiveness of the individual delivery of MBCT, with currently only evidence for the effectiveness of group-based MBCT.…”

Section: Discussionmentioning

confidence: 53%

Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

et al. 2014

View full text Add to dashboard Cite

OBJECTIVEDepression is a common comorbidity of diabetes, undesirably affecting patients' physical and mental functioning. Psychological interventions are effective treatments for depression in the general population as well as in patients with a chronic disease. The aim of this study was to assess the efficacy of individual mindfulnessbased cognitive therapy (MBCT) and individual cognitive behavior therapy (CBT) in comparison with a waiting-list control condition for treating depressive symptoms in adults with type 1 or type 2 diabetes. RESEARCH DESIGN AND METHODSIn this randomized controlled trial, 94 outpatients with diabetes and comorbid depressive symptoms (i.e., Beck Depression Inventory-II [BDI-II] ‡14) were randomized to MBCT (n = 31), CBT (n = 32), or waiting list (n = 31). All participants completed written questionnaires and interviews at pre-and postmeasurement (3 months later). Primary outcome measure was severity of depressive symptoms (BDI-II and Toronto Hamilton Depression Rating Scale). Anxiety (Generalized Anxiety Disorder 7), well-being (Well-Being Index), diabetes-related distress (Problem Areas In Diabetes), and HbA 1c levels were assessed as secondary outcomes. RESULTSResults showed that participants receiving MBCT and CBT reported significantly greater reductions in depressive symptoms compared with patients in the waitinglist control condition (respectively, P = 0.004 and P < 0.001; d = 0.80 and 1.00; clinically relevant improvement 26% and 29% vs. 4%). Both interventions also had significant positive effects on anxiety, well-being, and diabetes-related distress. No significant effect was found on HbA 1c values. CONCLUSIONSBoth individual MBCT and CBT are effective in improving a range of psychological symptoms in individuals with type 1 and type 2 diabetes.

show abstract

Section: Discussionmentioning

confidence: 53%

Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

et al. 2014

View full text Add to dashboard Cite

show abstract

“…However, since there are no reasons to assume a lack of efficacy for psychotherapy in these patients, treatment according to guidelines has to be provided. CBT is the psychotherapy with the best evidence for efficacy in patients with major depression [70]. In line with this, the recently published COPD-specific UK National Institute for Health and Care Excellence guidelines recommend ''identifying and managing anxiety and depression'' [60].…”

Section: Practical Consequencesmentioning

confidence: 95%

Depression and suicidality in COPD: understandable reaction or independent disorders?

Hegerl

Mergl

2014

European Respiratory Journal

View full text Add to dashboard Cite

Both depression and chronic obstructive pulmonary disease (COPD) are prevalent, severe and often comorbid disorders. There is a risk of undertreatment for depression in patients with COPD as depressive symptoms, including suicidal tendencies, can erroneously be conceptualised as an understandable reaction to COPD and not as signs of an independent depressive disorder. In this context, the comorbidity rates of COPD and depression, the risk of suicidal behaviour in patients with COPD, and the evidence base for pharmaco-and psychotherapy in these patients are reviewed.Because symptoms of depression and COPD overlap it remains unclear how far the prevalence of major depression in COPD exceeds that in the general population. The suicide risk appears to be increased in COPD. Methodological studies providing evidence for the antidepressant efficacy of antidepressants or psychotherapy in patients with COPD are lacking. Recommendations for clinicians on how to separate depression from an understandable reaction to COPD are provided.Given the profound effects of depression on quality of life, life expectancy, COPD prognosis and suicide risk it is important to carefully diagnose and treat depression in patients with COPD according to national guidelines. @ERSpublications Comorbid depression has profound effects on COPD prognosis and should not be seen as understandable reaction to COPD

show abstract

“…Although behavioral treatments for anxiety disorders are highly effective in reducing symptoms of anxiety (Butler, Chapman, Forman, & Beck, 2006;Hofmann & Smits, 2008;Tolin, 2010), many patients do not improve, drop out of treatment, or relapse (Arch & Craske, 2009;Clark et al, 2006;Davidson et al, 2004). Given the need to improve treatments, the goal of the current project is to translate neuroscience research to enhancing the effectiveness of exposure therapy for public speaking anxiety.…”

mentioning

confidence: 99%

Affect labeling enhances exposure effectiveness for public speaking anxiety

Niles

Craske

Lieberman

et al. 2015

Behaviour Research and Therapy

View full text Add to dashboard Cite

a b s t r a c tExposure is an effective treatment for anxiety but many patients do not respond fully. Affect labeling (labeling emotional experience) attenuates emotional responding. The current project examined whether affect labeling enhances exposure effectiveness in participants with public speaking anxiety. Participants were randomized to exposure with or without affect labeling. Physiological arousal and selfreported fear were assessed before and after exposure and compared between groups. Consistent with hypotheses, participants assigned to Affect Labeling, especially those who used more labels during exposure, showed greater reduction in physiological activation than Control participants. No effect was found for self-report measures. Also, greater emotion regulation deficits at baseline predicted more benefit in physiological arousal from exposure combined with affect labeling than exposure alone. The current research provides evidence that behavioral strategies that target prefrontal-amygdala circuitry can improve treatment effectiveness for anxiety and these effects are particularly pronounced for patients with the greatest deficits in emotion regulation.

show abstract

Is cognitive–behavioral therapy more effective than other therapies?A meta-analytic review

Cited by 541 publications

References 71 publications

Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

Individual Mindfulness-Based Cognitive Therapy and Cognitive Behavior Therapy for Treating Depressive Symptoms in Patients With Diabetes: Results of a Randomized Controlled Trial

Depression and suicidality in COPD: understandable reaction or independent disorders?

Affect labeling enhances exposure effectiveness for public speaking anxiety

Contact Info

Product

Resources

About